Sabari, Joshua K.
Lok, Benjamin H.
Laird, James H.
Poirier, John T.
Rudin, Charles M.
Article History
First Online: 23 May 2017
Competing interests
: C.M.R. has been a paid consultant regarding oncology drug development for Bristol-Myers Squibb, Celgene, G1 Therapeutics, Harpoon Therapeutics, Medivation, and Novartis. The other authors declare no competing interests.